Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stattin

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1997
Prognostic factors in prostate cancerP Stattin
British Journal of Cancer|October 30, 2003
Prostate cancer, insulin, and androgen deprivation therapyP Stattin, R Kaaks
Scandinavian Journal of Urology and Nephrology|April 1, 1996
Long-term outcome of patients treated for hydrocele with the sclerosant agent sodium tetradecyl sulphateP Stattin, L Karlberg, J E Damber
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 3, 1999
Predictive value of bcl-2 immunoreactivity in prostate cancer patients treated with radiotherapyA Bylund, P Stattin, A Widmark, et al.
The Journal of Urology|January 1, 1997
Cell proliferation assessed by Ki-67 immunoreactivity on formalin fixed tissues is a predictive factor for survival in prostate cancerP Stattin, J E Damber, L Karlberg, et al.
British Journal of Cancer|March 4, 1998
Short-term cellular effects induced by castration therapy in relation to clinical outcome in prostate cancerP Stattin, P Westin, J E Damber, et al.
Journal of the National Cancer Institute|August 14, 2010
Re: Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United StatesP Stattin, H Garmo, G Steineck, et al.
The American Journal of Pathology|June 1, 1995
Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumorsP Westin, P Stattin, J E Damber, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1996
Pretreatment p53 immunoreactivity does not infer radioresistance in prostate cancer patientsP Stattin, J E Damber, H Modig, et al.
Scandinavian Journal of Urology and Nephrology|August 31, 2002
Transrectal core biopsy trauma may increase cell proliferation in prostate tumorsA Bergh, A Bylund, E Lundin, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1997
Prognostic factors in prostate cancerP Stattin
British Journal of Cancer|October 30, 2003
Prostate cancer, insulin, and androgen deprivation therapyP Stattin, R Kaaks
Scandinavian Journal of Urology and Nephrology|April 1, 1996
Long-term outcome of patients treated for hydrocele with the sclerosant agent sodium tetradecyl sulphateP Stattin, L Karlberg, J E Damber
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 3, 1999
Predictive value of bcl-2 immunoreactivity in prostate cancer patients treated with radiotherapyA Bylund, P Stattin, A Widmark, et al.
The Journal of Urology|January 1, 1997
Cell proliferation assessed by Ki-67 immunoreactivity on formalin fixed tissues is a predictive factor for survival in prostate cancerP Stattin, J E Damber, L Karlberg, et al.
British Journal of Cancer|March 4, 1998
Short-term cellular effects induced by castration therapy in relation to clinical outcome in prostate cancerP Stattin, P Westin, J E Damber, et al.
Journal of the National Cancer Institute|August 14, 2010
Re: Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United StatesP Stattin, H Garmo, G Steineck, et al.
The American Journal of Pathology|June 1, 1995
Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumorsP Westin, P Stattin, J E Damber, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1996
Pretreatment p53 immunoreactivity does not infer radioresistance in prostate cancer patientsP Stattin, J E Damber, H Modig, et al.
Scandinavian Journal of Urology and Nephrology|August 31, 2002
Transrectal core biopsy trauma may increase cell proliferation in prostate tumorsA Bergh, A Bylund, E Lundin, et al.
Pageof 6